Marta Torres-Moreno

Valencia, VC 46010, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

The aryl hydrocarbon receptor is downregulated in MASLD while its activation attenuates steatosis in human hepatocytes through an IGFBP1-associated pathway.

The aryl hydrocarbon receptor is downregulated in MASLD while its activation attenuates steatosis in human hepatocytes through an IGFBP1-associated pathway.

Journal: Archives of toxicology

Published: May 14, 2026

Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes.

Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes.

Journal: Archives of toxicology

Published: June 20, 2025

Unravelling drug-induced hepatic steatosis: Clinical sub-phenotypes, outcome prediction, and identification of high-concern drugs and hazardous chemical attributes.

Unravelling drug-induced hepatic steatosis: Clinical sub-phenotypes, outcome prediction, and identification of high-concern drugs and hazardous chemical attributes.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 09, 2025

Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide.

Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide.

Journal: Transplantation and cellular therapy

Published: April 07, 2025

The acyl glucuronide of 2-(4-diethylamino-2-hydroxybenzoyl)benzoic acid: Synthesis, structural assignment, occurrence as a human phase II metabolite of Uvinul® A Plus and acute aquatic toxicity.

The acyl glucuronide of 2-(4-diethylamino-2-hydroxybenzoyl)benzoic acid: Synthesis, structural assignment, occurrence as a human phase II metabolite of Uvinul® A Plus and acute aquatic toxicity.

Journal: Chemosphere

Published: December 30, 2024

Corrigendum to "Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support" [Biomed. Pharmacother. 174 (2024) 116530].

Corrigendum to "Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support" [Biomed. Pharmacother. 174 (2024) 116530].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 24, 2024

Improving insights from metabolomic functional analysis combining multivariate tools.

Improving insights from metabolomic functional analysis combining multivariate tools.

Journal: Analytica chimica acta

Published: May 23, 2024

Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis.

Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis.

Journal: International journal of molecular sciences

Published: February 05, 2024

Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support.

Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 25, 2024

Cluster-Partial Least Squares (c-PLS) regression analysis: Application to miRNA and metabolomic data.

Cluster-Partial Least Squares (c-PLS) regression analysis: Application to miRNA and metabolomic data.

Journal: Analytica chimica acta

Published: October 13, 2023

Enhancing the accuracy of mid-infrared spectroscopy-based liver steatosis quantification using digital image analysis as a reference.

Enhancing the accuracy of mid-infrared spectroscopy-based liver steatosis quantification using digital image analysis as a reference.

Journal: The Analyst

Published: June 14, 2023

The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics.

The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics.

Journal: Frontiers in pharmacology

Published: January 31, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026